Despite Big M&As, Life-Science Startups Aren't Too Lively These Days
Published: Jun 12, 2014
The profusion of big mergers in pharmaceuticals, such as Valeant Pharmaceuticals International’s $54 billion offer for Allergan (AGN), creates the impression that the life-science sector is booming. But the pipeline of new companies is going dry, according to a new study. Hey, check out all the research scientist jobs. Post your resume today!